Company page

Scinopharm Taiwan, Ltd.

Scinopharm Taiwan, Ltd. is a publicly traded company on the Taiwan stock market under the ticker 1789. The company has a market capitalization of approximately NT$482.49 million. Scinopharm specializes in the development and manufacturing of pharmaceutical products.

profile1789AI content: aiUpdated May 29, 2026/company/scinopharm-taiwan-ltd
Scinopharm Taiwan, Ltd. logo
Ticker
1789
Market cap
$482.5M
Sector
Health Technology
Industry
Biotechnology